Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor-Reference-Cited by-同舟云学术

Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor

Published:2009-08-24 Issue:13 Volume:23 Page:1631-1640
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Ho Sarah K,Perez Elena E,Rose Stephanie L,Coman Roxana M,Lowe Amanda C,Hou Wei,Ma Changxing,Lawrence Robert M,Dunn Ben M,Sleasman John W,Goodenow Maureen M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference44 articles.

1. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1;Martinez-Picado;J Virol,2006

2. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors;Doyon;J Virol,1996

3. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients;Mammano;J Virol,1998

4. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites;Zhang;J Virol,1997

5. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease;Goodenow;Virology,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length gag-protease genes;Journal of Antimicrobial Chemotherapy;2014-08-04

2. Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges;Scientific Reports;2013-10-03

3. High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems;Retrovirology;2012-12

4. The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation;Journal of Leukocyte Biology;2012-10

5. A Cleavage Enzyme-Cytometric Bead Array Provides Biochemical Profiling of Resistance Mutations in HIV-1 Gag and Protease;Biochemistry;2011-04-27